15-90084323-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_002168.4(IDH2):āc.1302C>Gā(p.Thr434=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00185 in 1,614,006 control chromosomes in the GnomAD database, including 49 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0030 ( 7 hom., cov: 32)
Exomes š: 0.0017 ( 42 hom. )
Consequence
IDH2
NM_002168.4 synonymous
NM_002168.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.142
Genes affected
IDH2 (HGNC:5383): (isocitrate dehydrogenase (NADP(+)) 2) Isocitrate dehydrogenases catalyze the oxidative decarboxylation of isocitrate to 2-oxoglutarate. These enzymes belong to two distinct subclasses, one of which utilizes NAD(+) as the electron acceptor and the other NADP(+). Five isocitrate dehydrogenases have been reported: three NAD(+)-dependent isocitrate dehydrogenases, which localize to the mitochondrial matrix, and two NADP(+)-dependent isocitrate dehydrogenases, one of which is mitochondrial and the other predominantly cytosolic. Each NADP(+)-dependent isozyme is a homodimer. The protein encoded by this gene is the NADP(+)-dependent isocitrate dehydrogenase found in the mitochondria. It plays a role in intermediary metabolism and energy production. This protein may tightly associate or interact with the pyruvate dehydrogenase complex. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.59).
BP6
Variant 15-90084323-G-C is Benign according to our data. Variant chr15-90084323-G-C is described in ClinVar as [Benign]. Clinvar id is 791742.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.142 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.00305 (464/152246) while in subpopulation NFE AF= 0.0015 (102/68010). AF 95% confidence interval is 0.00126. There are 7 homozygotes in gnomad4. There are 342 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High AC in GnomAd4 at 464 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IDH2 | NM_002168.4 | c.1302C>G | p.Thr434= | synonymous_variant | 11/11 | ENST00000330062.8 | NP_002159.2 | |
IDH2 | NM_001289910.1 | c.1146C>G | p.Thr382= | synonymous_variant | 11/11 | NP_001276839.1 | ||
IDH2 | NM_001290114.2 | c.912C>G | p.Thr304= | synonymous_variant | 9/9 | NP_001277043.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IDH2 | ENST00000330062.8 | c.1302C>G | p.Thr434= | synonymous_variant | 11/11 | 1 | NM_002168.4 | ENSP00000331897 | P1 | |
IDH2 | ENST00000540499.2 | c.1146C>G | p.Thr382= | synonymous_variant | 11/11 | 2 | ENSP00000446147 | |||
IDH2 | ENST00000559482.5 | c.882C>G | p.Thr294= | synonymous_variant | 8/8 | 5 | ENSP00000453016 | |||
IDH2 | ENST00000560061.1 | c.*927C>G | 3_prime_UTR_variant, NMD_transcript_variant | 9/9 | 2 | ENSP00000453254 |
Frequencies
GnomAD3 genomes AF: 0.00305 AC: 464AN: 152128Hom.: 7 Cov.: 32
GnomAD3 genomes
AF:
AC:
464
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00347 AC: 871AN: 250978Hom.: 17 AF XY: 0.00339 AC XY: 460AN XY: 135686
GnomAD3 exomes
AF:
AC:
871
AN:
250978
Hom.:
AF XY:
AC XY:
460
AN XY:
135686
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00173 AC: 2526AN: 1461760Hom.: 42 Cov.: 31 AF XY: 0.00176 AC XY: 1277AN XY: 727164
GnomAD4 exome
AF:
AC:
2526
AN:
1461760
Hom.:
Cov.:
31
AF XY:
AC XY:
1277
AN XY:
727164
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00305 AC: 464AN: 152246Hom.: 7 Cov.: 32 AF XY: 0.00460 AC XY: 342AN XY: 74422
GnomAD4 genome
AF:
AC:
464
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
342
AN XY:
74422
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Feb 01, 2024 | IDH2: BS1, BS2 - |
D-2-hydroxyglutaric aciduria 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 19, 2024 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at